These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28922812)

  • 1. Treatment of Mycobacterium avium-intracellulare complex: a great leap forward.
    Alffenaar JC; van Ingen J
    J Antimicrob Chemother; 2017 Sep; 72(suppl_2):i1-i2. PubMed ID: 28922812
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates.
    Kobashi Y; Yoshida K; Miyashita N; Niki Y; Oka M
    J Infect Chemother; 2006 Aug; 12(4):195-202. PubMed ID: 16944258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preclinical study of therapeutic agents used against Mycobacterium avium complex infections--with special reference to new macrolides and new quinolones].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1996 Sep; 71(9):531-5. PubMed ID: 8999135
    [No Abstract]   [Full Text] [Related]  

  • 4. Is delamanid a potential agent in the treatment of diseases caused by Mycobacterium avium-intracellulare?
    Krieger D; Schönfeld N; Vesenbeckh S; Bettermann G; Bauer TT; Rüssmann H; Mauch H
    Eur Respir J; 2016 Dec; 48(6):1803-1804. PubMed ID: 27836960
    [No Abstract]   [Full Text] [Related]  

  • 5. Susceptibility testing of Mycobacterium avium complex isolates.
    Heifets L
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1759-67. PubMed ID: 8843278
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diagnostic image. An old man with a cough].
    de Vries GJ
    Ned Tijdschr Geneeskd; 2009; 153():B357. PubMed ID: 19785844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of combined therapy with ansamycin, clofazimine, ethambutol, and isoniazid for Mycobacterium avium infection in patients with AIDS.
    Agins BD; Berman DS; Spicehandler D; el-Sadr W; Simberkoff MS; Rahal JJ
    J Infect Dis; 1989 Apr; 159(4):784-7. PubMed ID: 2926169
    [No Abstract]   [Full Text] [Related]  

  • 8. Medical management of pulmonary disease caused by Mycobacterium avium complex.
    Iseman MD
    Clin Chest Med; 2002 Sep; 23(3):633-41, vii. PubMed ID: 12370999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical comparison between Mycobacterium avium and Mycobacterium intracellulare infections.
    Maesaki S; Kohno S; Koga H; Miyazaki Y; Kaku M
    Chest; 1993 Nov; 104(5):1408-11. PubMed ID: 8222796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.
    Bermudez LE; Inderlied CB; Kolonoski P; Petrofsky M; Aralar P; Wu M; Young LS
    Antimicrob Agents Chemother; 2001 Jan; 45(1):217-22. PubMed ID: 11120969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disseminated Mycobacterium avium complex infection.
    Inderlied CB; Kemper CA
    AIDS Clin Rev; 1992; ():131-72. PubMed ID: 1606056
    [No Abstract]   [Full Text] [Related]  

  • 12. Mycobacterium avium complex develop resistance to synergistically active drug combinations during infection.
    Hoffner SE; Heurlin N; Petrini B; Svenson SB; Källenius G
    Eur Respir J; 1994 Feb; 7(2):247-50. PubMed ID: 8162976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of clarithromycin-sensitive and clarithromycin-resistant Mycobacterium avium strains isolated from AIDS patients during therapy regimens including clarithromycin.
    Matsiota-Bernard P; Zinzendorf N; Onody C; Guenounou M
    J Infect; 2000 Jan; 40(1):49-54. PubMed ID: 10762111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Antibiotic Approved for Refractory Mycobacterium Avium Complex.
    Aschenbrenner DS
    Am J Nurs; 2019 Jan; 119(1):26. PubMed ID: 30589698
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnosis and treatment of infections due to Mycobacterium avium complex.
    Kasperbauer SH; Daley CL
    Semin Respir Crit Care Med; 2008 Oct; 29(5):569-76. PubMed ID: 18810690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic/pharmacodynamic-based treatment of disseminated Mycobacterium avium.
    Deshpande D; Gumbo T
    Future Microbiol; 2011 Apr; 6(4):433-9. PubMed ID: 21526944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterium avium disease: progress at last.
    Bates JH
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1737-8. PubMed ID: 8665029
    [No Abstract]   [Full Text] [Related]  

  • 18. Prospects for development of new antimycobacterial drugs.
    Tomioka H
    J Infect Chemother; 2000 Mar; 6(1):8-20. PubMed ID: 11810525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
    Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
    J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial activity and clinical efficacy of sparfloxacin in Mycobacterium avium-intracellulare complex infection.
    Horiguchi T; Kondo R; Miyazaki J; Shiga M; Sugiyama M; Handa M; Munekata E
    J Int Med Res; 2004; 32(5):530-9. PubMed ID: 15458286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.